AI, Collaborations, Competitor News

Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines

Posted on

Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform from target identification through patient selection Research will be focused on up to 15 novel small…

AI, Competitor News, Product Updates

TriNetX Launches Machine Learning Capabilities on Global Real-World Data

Posted on

CAMBRIDGE, Mass., Jan. 6, 2022 /PRNewswire/ — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced the launch of its Bring Your Own Model (BYOM) product, a major step forward for the research community to apply custom machine learning models on global real-world…

AI, Competitor News

Q-Centrix and Realyze Intelligence Partner to Advance the Automation of High-Quality Clinical Data and Drive Better Patient Care

Posted on

CHICAGO, Jan. 06, 2022 (GLOBE NEWSWIRE) — Q-Centrix®, the largest exclusive provider of clinical data management solutions to hospitals and health systems, today announced a partnership with Realyze Intelligence, a company using artificial intelligence (AI) and natural language processing (NLP) to capture unstructured clinical data, ensuring patient populations with heart conditions or…

Asia-Pacific, Collaborations, Partner and Collaborator News

Palantir Technologies to Expand in South Korea

Posted on

– Hyundai Heavy Industries (HHI) Group and Palantir Technologies to establish a big data platform for HHI Group’s core businesses – Palantir Technologies and Hyundai Heavy Industries plan to form a joint venture to commercialize big data solutions – Hyundai Heavy Industries will deploy Palantir Foundry DENVER & SEOUL, South Korea–(BUSINESS WIRE)–Hyundai Heavy…

Competitor News, Fundraising/IPO, Product Updates

Syntegra Raises $5.625M in Seed Financing

Posted on

Financing will help drive Syntegra’s mission of accelerating data-centric research and innovation through AI-generated synthetic data SAN FRANCISCO, CA, January 4, 2022 â€“ Syntegra, a leader in synthetic healthcare data generation, today announced it has closed its seed financing, bringing in a total of $5.625 million. Syntegra’s investors include Sweat Equity Ventures,…

Competitor News, HR

Stephanie Reisinger to Lead Flatiron Health’s Real-World Evidence Business

Posted on

Former Veradigm Executive Brings Extensive Experience in EHR-Derived Real-World Data  NEW YORK, NY, January 5, 2022 Flatiron Health® today announced the appointment of Stephanie Reisinger as Senior Vice President and General Manager, Real-World Evidence (RWE), driving long-term strategy and growth for Flatiron’s RWE business unit. “Stephanie brings a unique mix of…

Competitor News, HR

Osmind Expands Senior Leadership Team With Addition of Chief Growth Officer and Scientific Advisory Board Members

Posted on

SAN FRANCISCO–(BUSINESS WIRE)–Osmind, the healthcare technology company and Public Benefit Corporation that is building the first digital infrastructure for neuropsychiatry and provides the #1 Electronic Health Record (EHR) software for innovative mental health practices, announced today that it has added new members to its leadership and Scientific Advisory Board to…

Europe, Industry News

MHRA Guidance on the use of Real-World Data in Clinical Studies for Regulatory Decision-Making Supports Albert Labs’ Licensing Pathway

Posted on

VANCOUVER, BC, Jan. 4, 2022 /CNW/ – On the 17th December 2021 the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) produced guidance acknowledging and setting out the criteria for the use of Real World Data and Evidence in regulatory decision making. This guidance is consistent with Albert Labs’ strategy, one of the first psychedelic drug…

Competitor News, M&A

EVERSANA completes acquisition of Intouch Group, adds the premiere digital-first agency network to the market leader in next generation commercialization

Posted on

CHICAGO and KANSAS CITY, Mo., Dec. 21, 2021 /PRNewswire/ — EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced it has completed its acquisition of Intouch Group®, a full-service global agency network serving the pharmaceutical industry. The acquisition immediately propels EVERSANA’s position as a $1 billion commercial services leader with more than…